|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 281, Issue 43, 32156-32163, October 27, 2006
A Conserved NXIP Motif Is Required for Cell Adhesion Properties of the Syndecan-4 Ectodomain*
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
1 integrins in several cell types. | INTRODUCTION |
|---|
|
|
|---|
5
1 integrin. Fibroblasts form focal adhesions in response to fibronectin fragments containing the integrin binding (RGD-containing) and heparin binding domains. Integrin engagement is not sufficient to stimulate this process, and the heparan sulfate binding occurs through syndecan-4 (57). The cytoplasmic domain of syndecan-4 can interact with a range of proteins. As with all syndecans, the C2 region of the cytoplasmic domain of syndecan-4 contains a PDZ binding site, and PDZ proteins, such as GIPC (GAIP-interacting protein-C terminus) and syntenin, have been shown to bind (8, 9). The dimeric syndecan-4 cytoplasmic domain is stabilized by phosphatidylinositol 4,5-bisphosphate interactions with the V region (10). In turn, protein kinase C
binds and is persistently activated (1113), and syndecan-4 is able to recruit protein kinase C
to focal adhesions (14). The V region can also interact with
-actinin and syndesmos with potential linkage to the cytoskeleton (15, 16), whereas overexpression of rat syndecan-4 results in a reduction in cell migration (17).
Evidence suggests that the syndecan-4 ectodomain may have biological activity (18, 19). Syndecan-4 fusion proteins expressed in prokaryotic systems support fibroblast attachment when used as substrates in adhesion assays. This activity was mapped to a 54-residue region of the murine syndecan-4 ectodomain between the GAG attachment sites and the transmembrane domain. This putative cell binding domain was shown to completely inhibit fibroblast attachment to the full-length syndecan-4 ectodomain substratum when used in competition assays (18, 19). Syndecan-1 ectodomain may also possess important biological activity. MDA-MB-231 mammary carcinoma cells overexpressing syndecan-1 seeded on cognate antibodies resulted in spreading in an
5
3-dependent manner after exogenous integrin activation by manganese ions (20). This effect was observed with constructs expressing cytoplasmic domain-null and heparan sulfate-null forms of syndecan-1 and could only be compromised when amino acids 88252 of the ectodomain had been deleted (21). Syndecan-1 ectodomain can regulate ARH77 mammary carcinoma migration into collagen gels; this effect was mapped to a five-residue sequence AVAAV in murine syndecan-1. However, when this hydrophobic sequence was deleted, only matrix invasion was affected, and syndecan-1-mediated spreading and binding was unaffected by this mutation (22). Recently, recombinant syndecan-2 ectodomain has been shown to promote capillary tube formation in microvascular endothelial cells when incorporated into matrigel (23).
Here we have shown that the cell adhesion activity of the syndecan-4 ectodomain is conserved across vertebrate evolution and that adhesion activity is restricted to mesenchymal and leukocytic cells. Epithelial cell lines appear not to interact with this protein. We have also identified a conserved NXIP motif within the syndecan-4 ectodomain that is important for cell adhesion. Finally, we have also shown evidence that the cellular response to the syndecan-4 ectodomain involves
1 integrins.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
minimal essential medium (Cambrex) in the presence of 5% fetal calf serum (FCS). Swiss 3T3, Madin-Darby canine kidney cells, T47D, Ovcar3, mouse skin endothelial cells, MCF7, and COS7 cells were grown in Dulbecco's modified Eagle's medium (Cambrex) supplemented with 10% FCS. HEK293 and Jurkat cells were cultured in Dulbecco's modified Eagle's/F-12 (Invitrogen) media with 10% FCS, whereas K562 were grown in RPMI 1640 medium (Invitrogen) with 5% FCS.
Cloning of Zebrafish Syndecan-4Plasmids and primers are listed in supplemental Table S1. The expressed sequence tag clone IMAGp998K2410802Q3 corresponding to the zebrafish homologue of syndecan-4 was obtained from Deutsches Ressourcenzentrum für Genomschung GmbH (Berlin, Germany) and sequenced by conventional methods. The 5'-end of zebrafish syndecan-4 cDNA was obtained using 5'-RACE (Invitrogen). Briefly, zebrafish syndecan-4 cDNA was prepared by reverse transcription using primer ZebSDC4rev, and this was used as a template in sequential PCR reactions, using primer Zeb4gsp1 in the primary PCR and Zeb4gsp2 in the secondary PCR. The blunt-ended PCR products were phosphorylated using T4 polynucleotide kinase (Invitrogen) and ligated into the EcoRV site of pBluescript II KS(±) (Stratagene) using standard procedures. Using the newly generated 5' sequence, the full-length gene sequence of the zebrafish syndecan-4 was amplified by reverse transcription-PCR from 24-h zebrafish embryo RNA using oligo(dT) and PCR primers Zeb4PstI and Zeb4BamHI. The resultant PCR product was digested with BamHI and PstI and ligated into the corresponding sites of pBluescript II KS(±) to construct the pBSZebSDC4pr plasmid.
Glutathione S-Transferase (GST) Ectodomain Fusion Proteins; Construct Generation, Protein Expression, and PurificationPlasmids containing the full-length syndecan-4 cDNAs from human, mouse, and zebrafish were used as templates for PCR. The human, mouse, and zebrafish ectodomain sequences were amplified using the primer pairs S4petA and S4petB, MouEDfor and MouEDrev, and ZebEDfor and ZebEDrev, respectively. PCR products were kinased and digested with BamHI prior to ligation into the PshAI and BamHI sites of the bacterial expression vector pET41(a+) (Novagen). Human syndecan-4 ectodomain mutants were made using a PCR-based approach. Primer pairs SNKVSMfor and SNKVSMrev, NEVfor and NEVrev, or NHIPfor and NHIPrev were used to amplify linear pGSThS4ED. The primer positions were designed such that the PCR product from each respective primer pair would lack the coding sequence for the amino acid sequences 125SNKVSM130, 109NEV111, or 87NHIP90. PCR products were digested with DpnI and column-purified (Qiagen) prior to ligation and transformation. Successful deletion was verified by DNA sequencing. Alanine-scanning mutations of the NHIP motif were prepared using a similar method. pGSThS4ED-NHIP was used as the PCR template, and primer NHIPrev was used with primers NHIPN-A, NHIPH-A, NHIPI-A, and NHIPP-A to yield plasmids pGSThS4EDN-A, pGSThS4EDH-A, pGSThS4EDI-A, and pGSThS4EDP-A. GST fusion proteins containing either the cell binding domain (Pro76Ser152) or the remaining N-terminal fragment (Glu24Gly75) of the syndecan-4 ectodomain were made as follows. Human syndecan-4 sequence coding from Pro76Ser152 was PCR-amplified using primers CBDa and CBDb and cloned into the PshAI and BamHI sites of pET41(a+) to make the plasmid pGSTHS4EDcbd. Using the same PCR mutagenesis protocol as above, a stop codon was introduced into the human syndecan-4 ectodomain coding sequence after Gly75. pGSTHS4ED was used as the template in conjunction with primers S4ectfrfor and S4ectfrrev, and the resultant PCR product was digested and ligated as above to produce pGSTHS4EDfr.
Plasmids were transformed into the Escherichia coli BL21 strain (Promega), and the bacteria were grown to an A600 of 0.6 at 37 °C prior to the addition of 0.25 ml/liter 1 M isopropyl 1-thio-
-D-galactopyranoside (Calbiochem) followed by a further 3-h incubation. Bacteria were resuspended in phosphate-buffered saline (PBS), lysed in a sonicator, and GST syndecan-4 ectodomain fusion proteins were purified on columns of glutathione-Sepharose 4B (GE Healthcare) as described in the manufacturer's protocol.
Cell Adhesion AssayAdhesion assays were performed using 24-well plates. The wells were coated either with 0.25 ml of the various syndecan-4 ectodomain fusion proteins at concentrations up to 10 µg/ml or with 5% bovine serum albumin (BSA) overnight at 4 °C, and human plasma fibronectin (10 µg/ml) was purified according the method described in Ref. 25. The wells were washed once with PBS and blocked using 1% w/v BSA for 1 h at 37°C followed by two washes with PBS. Cells were detached using trypsin/EDTA and suspended in serum-containing medium. The cells were sedimented and resuspended in serum-free medium to a concentration of 2.5 x 105 cells/ml, and 0.2 ml of cell suspension/well was used in the assay. The non-adherent cell lines K562 and Jurkat were incubated for 15 min in serum-free medium containing 10 ng/ml phorbol 12-myristate 13-acetate (PMA) prior to seeding on substrates. The blocking antibodies AIIb2, Ha2/5 (Chemicon), and LM609 (Chemicon) were used at a concentration of 10 µg/ml; REF, Swiss 3T3, COS7, and Jurkat cells (PMA-treated as above) were incubated at 4 °C for 30 min in serum-free medium in the presence or absence of antibody and then seeded on substrate at 37 °C. Unless stated otherwise, the cells were allowed to adhere for 1 h at 37 °C, after which time the medium was removed and replaced with serum-free medium containing 15 µM calcein (Invitrogen) and incubated for a further 20 min. The wells were washed twice with PBS, and cell-bound fluorescence was measured using a Fluostar Galaxy Plate reader (BMG Lab Technologies) at 485 nm excitation and 520 nm emission.
Immunofluorescence MicroscopyCoverslips were coated overnight with the appropriate substrate, and cells were seeded in serum-free conditions and allowed to spread for 1 h. The cells were then fixed for 20 min in 4% paraformaldehyde in PBS followed by permeabilization with 0.1% Triton X-100 in PBS for 10 min. Thereafter, the cells were stained using conventional procedures with AlexaFluor 568-conjugated phalloidin (Molecular Probes) for F-actin and to detect focal adhesions, anti-vinculin (Sigma) followed by AlexaFluor 488-conjugated goat anti-mouse IgG (Molecular Probes) was used. The samples were analyzed on a Provis AX module fluorescence microscope (Olympus; objectives were UPlanApo 40 x 1.0 oil iris and UPlanApo 60 x 1.4 oil). Images were collected using a SPOT Insight Mono digital camera and processed in Adobe Photoshop.
|
|
| RESULTS |
|---|
|
|
|---|
Divergent Vertebrate Syndecan-4 Ectodomains Support Mesenchymal Cell AdhesionBacterially expressed mouse syndecan-4 ectodomain can support cell adhesion when used as a substratum for attachment assays (18, 19). GST fusion proteins containing the ectodomains of human (GSThS4ED), mouse (GSTmS4ED), and zebrafish (GSTzS4ED) syndecan-4 were prepared (Fig. 2, A and B). In each case, the ectodomain protein did not include either the signal sequence or the four amino acids immediately proximal to the transmembrane domain (Fig. 2A). Cleavage of the GST from the fusion proteins was unsuccessful, because syndecan-4 ectodomains aggregate to form insoluble complexes. The GST fusion proteins, however, remained dimeric and soluble (Fig. 2B). Cell attachment assays were performed using the three GST ectodomains, human plasma fibronectin, GST, and BSA, as substrates. REFs attached well to fibronectin and failed to adhere to either BSA or GST. As reported previously (18), the GSTmS4ED also supported cell attachment and equivalent activity was observed for the human and zebrafish ectodomains (Fig. 2C). This effect was not restricted to REFs, because Swiss 3T3 and mouse skin endothelial cells also exhibited similar levels of attachment to each syndecan-4 ectodomain. Further analysis revealed that, although a number of mesenchymal cell lines adhered to syndecan-4 ectodomain, all of the epithelial cell lines (except endothelial cells) failed to do so (Fig. 2C and Table 1). Leukocytic cell lines were variable; Jurkat cells adhered to the syndecan-4 ectodomains after PMA stimulation, whereas K562 cells were unresponsive.
|
|
NHIP was any more unstable than the wild-type fusion protein (Fig. 4A). No further compromise of cell attachment or spreading on the GSThS4ED
NHIP was obtained from additional deletions of the NEV conserved motif or the 4-amino-acid proline-rich region immediately preceding the NHIP sequence. Neither substrate showed any reduction in cell attachment properties (supplemental Fig. S3B). Identical results to REFs in terms of adhesion were seen with Swiss 3T3 and Jurkat cells to each of these deletion mutants (data not shown).
|
|
|
Ala mutant alone showed compromised cell attachment and spreading properties (Fig. 5, C and D). As described previously, all of the alanine scanning mutants had similar coating properties to wild-type GST syndecan-4 ectodomain fusion protein (supplemental Fig. S3C), and these mutants were as stable as the wild-type protein (Fig. 5B).
Cell Adhesion to the Syndecan-4 Ectodomain Is Integrin-dependentCell adhesion and spreading responses to the syndecan ectodomain could have resulted from association between the exogenous recombinant syndecan-4 protein and endogenously expressed syndecan-4. However, because syndecan-4 null fibroblasts adhered to all three forms of syndecan-4 ectodomain fusion protein, this was effectively ruled out. As shown in Fig. 3C, cells seeded on the syndecan-4 ectodomain spread with actin organized in a cortical distribution. This was suggestive of integrin involvement and was further supported by the use of EDTA, where REF failed to attach to the human form of the syndecan-4 ectodomain (Fig. 6A). Because Jurkat cell attachment to syndecan-4 ectodomains required phorbol ester pretreatment (Fig. 6B and Table 1), this also suggested a role for integrins. Integrin involvement was confirmed with the
1 integrin-blocking antibodies AIIb2, which inhibited PMA-induced adhesion of Jurkat cells to GSThS4ED (Fig. 6B) and Ha2/5 and which compromised REF and Swiss 3T3 fibroblast attachment (Fig. 6C). The Ha2/5 antibody also compromised REF attachment to the GST fusion protein containing only the cell binding domain of syndecan-4 (supplemental Fig. S2C). The
V
3 integrin-blocking antibody LM609 had no effect on the adhesion of COS7 cells to GSThS4ED but did block adhesion to serumcoated substrate (Fig. 6D).
| DISCUSSION |
|---|
|
|
|---|
It has been shown here that cell adhesion to the syndecan-4 ectodomain is sensitive to the blockade of the
1 integrin but not
V
3 integrin. This is consistent with experiments showing the requirement for divalent cations as well as the finding that Jurkat adhesion to the syndecan-4 ectodomain requires activation of protein kinase C through phorbol ester treatment. This is a known property of Jurkat integrins (26). Once again, however, it reveals that adhesion to syndecan-4 ectodomain through integrins may be complex, because many cell types, including epithelial cells, possess
1 integrins. Altogether this suggests that mesenchymal cells and Jurkat cells possess an intermediate that is responsible for the bridging between syndecan-4 and the
1 integrin. The identity of this intermediate remains unknown but could be predicted to be absent in epithelial cells.
In the case of syndecan-1 ectodomain, MDA-MB-231 cell adhesion is dependent on the
V
3 integrin, whereas in B82L fibroblasts, adhesion is dependent on the
V
5 integrin (21, 27). Because the adhesion of fibroblasts to syndecan-4 ectodomains is a well conserved function, demonstrable in lower vertebrates, this appears to be an important function of syndecan-4 worthy of further exploration. It may, in part, explain the special relationship that syndecan has with integrins in adhesion to extracellular molecules such as fibronectin. Of the four vertebrate syndecan family members, only syndecan-4 has the ability to become incorporated into focal adhesions, but it is not yet understood whether this involves the ectodomain site identified here. The present experiments report on the activity of syndecan-4 in trans, a feature that has also been suggested to occur in Xenopus development with respect to syndecan-2 (28). So far, syndecan-4 regulation of focal adhesion formation has been suggested to be in cis but should now be further investigated.
| FOOTNOTES |
|---|
The on-line version of this article (available at http://www.jbc.org) contains supplemental material. ![]()
1 To whom correspondence should be addressed: Biomedical Sciences Div., Faculty of Natural Sciences, Imperial College London, Sir Alexander Fleming Bldg., Exhibition Rd., London SW7 2AZ, UK. Tel.: 44-2075943190; E-mail: j.couchman{at}imperial.ac.uk.
2 The abbreviations used are: REF, rat embryo fibroblast; FCS, fetal calf serum; RACE, rapid amplification of cDNA ends; GST, glutathione S-transferase; PBS, phosphate-buffered saline; BSA, bovine serum albumin; PMA, phorbol 12-myristate 13-acetate. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. D. Bass, M. R. Morgan, and M. J. Humphries Syndecans Shed Their Reputation as Inert Molecules Sci. Signal., March 31, 2009; 2(64): pe18 - pe18. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Beauvais, B. J. Ell, A. R. McWhorter, and A. C. Rapraeger Syndecan-1 regulates {alpha}v{beta}3 and {alpha}v{beta}5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor J. Exp. Med., March 16, 2009; 206(3): 691 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Whiteford, S. Ko, W. Lee, and J. R. Couchman Structural and Cell Adhesion Properties of Zebrafish Syndecan-4 Are Shared with Higher Vertebrates J. Biol. Chem., October 24, 2008; 283(43): 29322 - 29330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saito, H. Imazeki, S. Miura, T. Yoshimura, H. Okutsu, Y. Harada, T. Ohwaki, O. Nagao, S. Kamiya, R. Hayashi, et al. A Peptide Derived from Tenascin-C Induces 1 Integrin Activation through Syndecan-4 J. Biol. Chem., November 30, 2007; 282(48): 34929 - 34937. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |